W. M. Potts

1.0k total citations
21 papers, 769 citations indexed

About

W. M. Potts is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, W. M. Potts has authored 21 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 2 papers in Genetics. Recurrent topics in W. M. Potts's work include Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (7 papers) and Chemical Synthesis and Analysis (3 papers). W. M. Potts is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (7 papers) and Chemical Synthesis and Analysis (3 papers). W. M. Potts collaborates with scholars based in United States, Sweden and United Kingdom. W. M. Potts's co-authors include Timothy J. Lansing, J. Thomas Parsons, Jordi Vilà, Albert B. Reynolds, Michael J. Weber, Volker M. Vogt, J. Thomas Parsons, A B Reynolds, David Boettiger and Margaret A. Olsen and has published in prestigious journals such as The EMBO Journal, NeuroImage and Journal of Medicinal Chemistry.

In The Last Decade

W. M. Potts

21 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. M. Potts United States 12 486 232 86 73 72 21 769
Stephanie Rens‐Domiano United States 13 820 1.7× 362 1.6× 47 0.5× 34 0.5× 155 2.2× 15 1.1k
Michael A. Kjelsberg United States 10 688 1.4× 464 2.0× 27 0.3× 103 1.4× 75 1.0× 13 967
Patrick Poyet Canada 19 373 0.8× 169 0.7× 162 1.9× 64 0.9× 14 0.2× 32 1000
L Ellis United States 24 1.1k 2.2× 239 1.0× 105 1.2× 29 0.4× 150 2.1× 31 1.3k
Nadine Daniel France 8 373 0.8× 230 1.0× 40 0.5× 31 0.4× 38 0.5× 8 729
Susan M. Wade United States 20 768 1.6× 279 1.2× 51 0.6× 28 0.4× 39 0.5× 30 1.0k
Mark W. Strohsacker United States 8 340 0.7× 152 0.7× 35 0.4× 49 0.7× 52 0.7× 9 498
D J Kelleher United States 15 797 1.6× 333 1.4× 30 0.3× 54 0.7× 34 0.5× 16 952
Michael J. Karmilowicz United States 8 1.0k 2.1× 335 1.4× 109 1.3× 103 1.4× 21 0.3× 9 1.3k
Jan‐Eric Månsson Sweden 14 463 1.0× 159 0.7× 73 0.8× 31 0.4× 32 0.4× 19 914

Countries citing papers authored by W. M. Potts

Since Specialization
Citations

This map shows the geographic impact of W. M. Potts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. M. Potts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. M. Potts more than expected).

Fields of papers citing papers by W. M. Potts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. M. Potts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. M. Potts. The network helps show where W. M. Potts may publish in the future.

Co-authorship network of co-authors of W. M. Potts

This figure shows the co-authorship network connecting the top 25 collaborators of W. M. Potts. A scholar is included among the top collaborators of W. M. Potts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. M. Potts. W. M. Potts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Minli, Diansong Zhou, Yi Wang, et al.. (2011). Preclinical Pharmacology and Pharmacokinetics of AZD3783, a Selective 5-Hydroxytryptamine 1B Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 339(2). 567–578. 12 indexed citations
2.
Varnes, Jeffrey, Christopher R. Holmquist, Deidre Wilkins, et al.. (2010). Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1. Bioorganic & Medicinal Chemistry Letters. 20(16). 4878–4881. 3 indexed citations
3.
Pierson, M. Edward, Jan Andersson, Svante Nyberg, et al.. (2008). [11C]AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain. NeuroImage. 41(3). 1075–1085. 58 indexed citations
4.
Andersson, Jan, M. Edward Pierson, Sjoerd J. Finnema, et al.. (2008). [11C]AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET); Characterization in cynomolgus monkey brain. NeuroImage. 41. T19–T19. 2 indexed citations
5.
Albert, Jeffrey S. & W. M. Potts. (2006). Neurokinin-3 receptor antagonists in schizophrenia. Expert Opinion on Therapeutic Patents. 16(7). 925–937. 5 indexed citations
6.
Albert, Jeffrey S., Cyrus J. Ohnmacht, Peter R Bernstein, et al.. (2004). Design and optimization of cyclized NK1 antagonists with controlled atropisomeric properties. Tetrahedron. 60(20). 4337–4347. 28 indexed citations
7.
Albert, Jeffrey S., Cyrus J. Ohnmacht, Peter R Bernstein, et al.. (2003). Structural Analysis and Optimization of NK1 Receptor Antagonists through Modulation of Atropisomer Interconversion Properties. Journal of Medicinal Chemistry. 47(3). 519–529. 23 indexed citations
8.
Hay, Douglas W.P., Giuseppe Giardina, Don E. Griswold, et al.. (2002). Nonpeptide Tachykinin Receptor Antagonists. III. SB 235375, a Low Central Nervous System-Penetrant, Potent and Selective Neurokinin-3 Receptor Antagonist, Inhibits Citric Acid-Induced Cough and Airways Hyper-reactivity in Guinea Pigs. Journal of Pharmacology and Experimental Therapeutics. 300(1). 314–323. 75 indexed citations
9.
Bernstein, Peter R, David Aharony, Jeffrey S. Albert, et al.. (2001). Discovery of novel, orally active dual NK1/NK2 antagonists. Bioorganic & Medicinal Chemistry Letters. 11(20). 2769–2773. 29 indexed citations
10.
Sarau, Henry M., Don E. Griswold, W. M. Potts, et al.. (2000). Nonpeptide Tachykinin Receptor Antagonists. II. Pharmacological and Pharmacokinetic Profile of SB-222200, a Central Nervous System Penetrant, Potent and Selective NK-3 Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 295(1). 373–381. 59 indexed citations
11.
Sarau, Henry M., Don E. Griswold, W. M. Potts, et al.. (1997). Nonpeptide Tachykinin Receptor Antagonists: I. Pharmacological and Pharmacokinetic Characterization of SB 223412, a Novel, Potent and Selective Neurokinin-3 Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 281(3). 1303–1311. 87 indexed citations
12.
Potts, W. M., et al.. (1994). Alternatives for Powdery Mildew Control on Lilac. Arboriculture & Urban Forestry. 20(4). 227–230. 5 indexed citations
13.
Potts, W. M. & Volker M. Vogt. (1987). A simple method for immunoaffinity purification of nondenatured avian sarcoma and leukemia virus gag-containing proteins. Virology. 160(2). 494–497. 8 indexed citations
14.
Potts, W. M., Margaret A. Olsen, David Boettiger, & Volker M. Vogt. (1987). Epitope Mapping of Monoclonal Antibodies to gag Protein p19 of Avian Sarcoma and Leukaemia Viruses. Journal of General Virology. 68(12). 3177–3182. 73 indexed citations
15.
Reynolds, Albert B., Jordi Vilà, Timothy J. Lansing, et al.. (1987). Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus.. The EMBO Journal. 6(8). 2359–2364. 166 indexed citations
16.
Potts, W. M., et al.. (1954). Highly unsaturated fatty acids. II. Fractionation by urea inclusion compounds. Journal of the American Oil Chemists Society. 31(1). 16–20. 40 indexed citations
17.
Potts, W. M., et al.. (1953). The analysis and characterization of the oil from the seed of Citrullus colocynthis. Journal of the American Oil Chemists Society. 30(3). 118–120. 5 indexed citations
18.
Potts, W. M., et al.. (1952). The analysis and characterization of the oil from the seed of citrullus vulgaris. Journal of the American Oil Chemists Society. 29(11). 444–445. 4 indexed citations
19.
Potts, W. M., et al.. (1951). The analysis and characterization of the oil from the seed of stillingia sylvatica. Journal of the American Oil Chemists Society. 28(3). 87–88. 2 indexed citations
20.
Potts, W. M., et al.. (1951). An investigation of the oil from the seed of sebastiana lingustrina. Journal of the American Oil Chemists Society. 28(7). 292–294. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026